Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System

Table 2

Base-case costs estimates ($, year 2013 values) and utilities.

Parameter	Median	Range	Description and reference
Costs
Cost of 425 mg of apatinib	106.5	53.2~106.5	Local charge
Cost of palliative care in end of life	1483.9	1072.3~2119.3	Calculation
Cost of supportive care per cycle	117.1	32.3~322.6	Calculation
Utilities^&
Utility of disease-free	0.88	0.8~0.97	Measured
Utility of recurrent disease	0.41	0.28~0.63	Measured

^&The values were measured by the time trade-off (TTO).